Olstein Capital Management L.P. lessened its position in Equifax Inc. (NYSE:EFX - Free Report) by 20.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,000 shares of the credit services provider's stock after selling 2,000 shares during the period. Olstein Capital Management L.P.'s holdings in Equifax were worth $2,351,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. EntryPoint Capital LLC purchased a new stake in shares of Equifax in the 1st quarter worth about $30,000. Tortoise Investment Management LLC lifted its position in Equifax by 76.1% during the 2nd quarter. Tortoise Investment Management LLC now owns 125 shares of the credit services provider's stock valued at $30,000 after acquiring an additional 54 shares during the period. Mascoma Wealth Management LLC purchased a new position in Equifax during the 2nd quarter valued at about $30,000. Crewe Advisors LLC lifted its position in Equifax by 138.2% during the 2nd quarter. Crewe Advisors LLC now owns 131 shares of the credit services provider's stock valued at $32,000 after acquiring an additional 76 shares during the period. Finally, First Community Trust NA purchased a new position in Equifax during the 2nd quarter valued at about $33,000. Institutional investors own 96.20% of the company's stock.
Analyst Ratings Changes
Several research analysts have issued reports on EFX shares. Bank of America lifted their target price on shares of Equifax from $255.00 to $286.00 and gave the stock a "buy" rating in a report on Thursday, July 18th. Morgan Stanley lifted their price target on shares of Equifax from $250.00 to $271.00 and gave the stock an "equal weight" rating in a research note on Thursday, September 12th. Robert W. Baird lifted their price target on shares of Equifax from $290.00 to $333.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Wells Fargo & Company reiterated a "buy" rating on shares of Equifax in a research note on Friday, October 18th. Finally, Oppenheimer lifted their price target on shares of Equifax from $300.00 to $315.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $310.47.
Get Our Latest Research Report on Equifax
Insider Buying and Selling at Equifax
In related news, CEO Mark W. Begor sold 58,304 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $270.49, for a total value of $15,770,648.96. Following the completion of the transaction, the chief executive officer now directly owns 109,183 shares of the company's stock, valued at $29,532,909.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, EVP John J. Kelley III sold 1,000 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $272.92, for a total value of $272,920.00. Following the transaction, the executive vice president now owns 11,269 shares in the company, valued at approximately $3,075,535.48. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark W. Begor sold 58,304 shares of the stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $270.49, for a total transaction of $15,770,648.96. Following the completion of the transaction, the chief executive officer now owns 109,183 shares in the company, valued at approximately $29,532,909.67. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.66% of the company's stock.
Equifax Stock Up 2.0 %
Equifax stock traded up $5.31 during midday trading on Thursday, hitting $269.52. 1,036,420 shares of the company's stock were exchanged, compared to its average volume of 860,144. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.88 and a current ratio of 0.88. Equifax Inc. has a 12 month low of $180.31 and a 12 month high of $309.63. The firm has a 50-day moving average of $287.78 and a two-hundred day moving average of $265.19. The company has a market cap of $33.41 billion, a PE ratio of 58.71, a P/E/G ratio of 2.49 and a beta of 1.59.
Equifax (NYSE:EFX - Get Free Report) last issued its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. The company had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. Equifax had a net margin of 10.07% and a return on equity of 18.56%. The firm's quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.76 EPS. As a group, analysts expect that Equifax Inc. will post 7.29 earnings per share for the current fiscal year.
Equifax Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 0.58%. Equifax's payout ratio is 34.67%.
Equifax Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Read More
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.